NEWS MAKER @NEWS_MAKER
Pfizer and its partner BioNTech aim to offer updated boosters to people 12 and older, and shots could begin within weeks if the FDA quickly clears the modified vaccine - a step not expected to require waiting on new studies. https://t.co/75uIS7Tyav — PolitiTweet.org